Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Anti-rhesus IgG1/3 [1B3]-FITC

Anti-rhesus IgG1/3 [1B3]-FITC
Product Type: Antibodies for Assays (In Vitro)
Format: Anti-macaque IgG-FITC, 1B3, mouse variable region, mouse IgG1 Fc
Clone ID: [1B3]
RRID: AB_2819288
Common Names: Anti-rhesus IgG1/3 [1B3]-FITC | Anti-macaque IgG-FITC (min x human IgG) | Anti-macaque IgG [1B3] | 1B3.D2.F1 | PR-1233
Target: IgG1/3
Reactivity: Rhesus Macaque (Macaca mulatta) Cynomolgus Monkey (Macaca fascicularis)
Applications: in vitro; flow cytometry
Description:

1B3-FITC: mAb that reacts with macaque IgG (IgG1 and IgG3) but NOT human IgG.

 
Modifications: FITC
Restrictions: No
Sponsor: NIAID
How to cite (Methods): The Anti-rhesus IgG1/3 [1B3]-FITC antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat#PR-1233,RRID:AB_2819288).
How to cite (Acknowledgments): The Anti-rhesus IgG1/3 [1B3]-FITC antibody used in this study was provided by the NIH Nonhuman Primate Reagent Resource (NIAID U24 AI126683).

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2024